GHK-Cu 50MG

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) at 50 mg provides researchers with a mid-range quantity of this historically significant tripeptide-metal chelate, suitable for focused experimental programs and pilot studies. Discovered in the 1970s as a component of human serum that declined with age, GHK-Cu has since been subjected to rigorous investigation across multiple scientific disciplines. The peptide portion binds copper(II) ions with high affinity through its histidine and glycine residues, forming a stable complex that has shown remarkable activity in gene expression studies across many cell types.

Microarray analyses have revealed that GHK-Cu can modulate the expression of over 4,000 genes in human fibroblast cultures, with notable upregulation of genes associated with the ubiquitin-proteasome system, DNA repair mechanisms, and antioxidant defense pathways. Researchers have also examined the effects of GHK-Cu on transforming growth factor beta signaling, integrin expression, and focal adhesion kinase activation in keratinocytes and endothelial cells. The 50 mg quantity is optimal for investigators designing initial characterization experiments, establishing working concentrations, or conducting comparative studies against other copper-binding peptides and metal chelate complexes.

Each vial contains analytically verified GHK-Cu with purity and identity documentation provided. Coffee & Pepper Peptides offers this product strictly as a laboratory research reagent. It is not approved for human administration, topical application, or any clinical purpose.

FDA DISCLAIMER

The information provided on this website has not been evaluated by the U.S. Food and Drug Administration (FDA). None of the statements herein, nor any of the products offered, are intended to diagnose, treat, cure, or prevent any medical condition.

All products are supplied strictly as laboratory research reagents and are not for human consumption. We do not provide products to patients and do not make any claims regarding medical use.

Coffee & Pepper Peptides operates solely as a chemical supplier. It is not a compounding pharmacy and does not operate as a compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act.